Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$15.50
Change (%) Stock is Up 0.05 (0.32%)
Volume406,539
Data as of 12/09/16 1:57 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
11/17/16
Download Documentation Corporate Presentation November 2016

Recent News

More >>
DateTitle 
11/29/16Susan G. Komen® Joins Forces With Heron Therapeutics to Raise Awareness of the Supportive Care Needs of Patients With Breast CancerPrinter Friendly Version
11/08/16Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate ProgressPrinter Friendly Version
09/08/16Heron Therapeutics Announces Presentations of Results from Phase 2 Clinical Trial of HTX-011 in Hernia Repair at PAINWeek® 2016Printer Friendly Version
08/29/16Heron Therapeutics Announces Poster Presentations of Data from Phase 2 Clinical Program for HTX-011 at PAINWeek® 2016Printer Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.